Neuroendocrine Cancers: Patient Journey and Treatment in Latin America
Part of Cancer clinical trials.
This study looks at how people with certain neuroendocrine cancers (including small cell lung cancer and large-cell neuroendocrine carcinoma) are diagnosed and treated in Latin America. It aims to understand the patient journey and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You were diagnosed with a type of neuroendocrine cancer (including small cell lung cancer, large-cell neuroendocrine carcinoma, or extrapulmonary neuroendocrine cancer) between August 2014 and August 2024.
- Your medical records are available for the study team to review.
- A sample of your tumor (tissue block) from 2014 or later is available.
- You do not have another active cancer (except minor skin cancers or cervical cancer in situ).
- You are willing to give permission to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This study collects information from Chinese patients with a rare and aggressive type of cervical cancer called large cell neuroendocrine carcinoma. By tracking how the disease behaves and how patients respond, it aims to improve care for future patients.
This study looks at genetic markers in two types of lung cancer (small cell and large cell neuroendocrine) to understand why some tumors stop responding to a standard treatment that combines chemotherapy with immunotherapy. If you have one of these cancers and are about to start this treatment, you may be able to join.
This study looks at the medical records of people with advanced non-small cell lung cancer to understand what treatments they received and whether those treatments follow official guidelines. It may help doctors learn how to improve care for future patients.
This study looks at real-world treatment patterns and outcomes for people with advanced non-squamous non-small cell lung cancer in Brazil after standard treatments have failed. It aims to understand what happens next and how well different approaches work in everyday practice.
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
Hear when a new Neuroendocrine Carcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.